Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Dna X (SONM) Research & Development (2018 - 2025)

Historic Research & Development for Dna X (SONM) over the last 8 years, with Q3 2025 value amounting to $181000.0.

  • Dna X's Research & Development fell 7468.53% to $181000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $15.2 million, marking a year-over-year increase of 47385.08%. This contributed to the annual value of $14.2 million for FY2024, which is 70332.96% up from last year.
  • Latest data reveals that Dna X reported Research & Development of $181000.0 as of Q3 2025, which was down 7468.53% from $909000.0 recorded in Q2 2025.
  • Over the past 5 years, Dna X's Research & Development peaked at $12.5 million during Q4 2024, and registered a low of -$135000.0 during Q3 2022.
  • Moreover, its 5-year median value for Research & Development was $1.1 million (2022), whereas its average is $2.5 million.
  • Its Research & Development has fluctuated over the past 5 years, first crashed by 10245.81% in 2022, then surged by 125064.79% in 2024.
  • Dna X's Research & Development (Quarter) stood at $3.9 million in 2021, then crashed by 68.5% to $1.2 million in 2022, then decreased by 24.04% to $926000.0 in 2023, then surged by 1250.65% to $12.5 million in 2024, then plummeted by 98.55% to $181000.0 in 2025.
  • Its Research & Development was $181000.0 in Q3 2025, compared to $909000.0 in Q2 2025 and $1.6 million in Q1 2025.